Large-scale comparison of immunoassay- and aptamer-based plasma proteomics through genetics and disease

Grímur Hjörleifsson Eldjárn; Egil Ferkingstad; Sigrún H. Lund; Hannes Helgason; Ólafur Þ. Magnússon; Thorunn Asta Olafsdottir; Bjarni V. Halldórsson; Pall I. Olason; Florian Zink; Sigurjon Axel Gudjonsson; Garðar Sveinbjörnsson; Magnus I. Magnusson; Agnar Helgason; Ásmundur Oddsson; Gisli Hreinn Halldorsson; Magnús K. Magnússon; Saedís Saevarsdóttir; Thjodbjorg Eiriksdottir; Gísli Másson; Hreinn Stefánsson; Ingileif Jónsdóttir; Hilma Hólm; Þórunn Rafnar; Páll Melsted; Jona Saemundsdottir; Gudmundur Logi Norddahl; Guðmar Þorleifsson; Magnus Orn Ulfarsson; Daniel Fannar Gudbjartsson; Unnur Þorsteinsdóttir

doi:10.1101/2022.02.18.481034

GenomicsbioRxivFeb 18, 2022

Preprint

Large-scale comparison of immunoassay- and aptamer-based plasma proteomics through genetics and disease

Grímur Hjörleifsson Eldjárn iD, Egil Ferkingstad iD, Sigrún H. Lund iD, Hannes Helgason, Ólafur Þ. Magnússon iD, Thorunn Asta Olafsdottir iD, Bjarni V. Halldórsson iD, Pall I. Olason iD, Florian Zink, Sigurjon Axel Gudjonsson iD, Garðar Sveinbjörnsson iD, Magnus I. Magnusson iD, Agnar Helgason iD, Ásmundur Oddsson iD, Gisli Hreinn Halldorsson iD, Magnús K. Magnússon iD, Saedís Saevarsdóttir iD, Thjodbjorg Eiriksdottir iD, Gísli Másson iD, Hreinn Stefánsson iD, Ingileif Jónsdóttir iD, Hilma Hólm iD, Þórunn Rafnar iD, Páll Melsted iD, Jona Saemundsdottir, , Kāri Stefánsson iD

Abstract

The authors have withdrawn this manuscript because this paper was posted prematurely in advance of a UK Biobank Pharma Proteomics Project consortium effort. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author

PDF DOI